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The most important prognostic factor in patients with
breast cancer is the presence or absence of axillary lymph
node metastasis.(1) Although axillary lymph node dissec-
tion (ALND) can be the most accurate method to assess
axillary nodal status, it is related to significant physical
and psychological morbidity such as pain, lymphedema,
neuropathy, limited of motion in shoulder, etc.(2) In 1993,
Krag et al.(3)performed a pilot study on a technique using
gamma probe localization of sentinel lymph node (SLN)
labeled with radiocolloid. They proposed that lympho-
scintigraphy has a potential value in localizing SLNs.
They also found that those SLNs selectively dissected
using the lymphoscintigraphy appear to predict the status
of the entire axillary lymph nodes. Since then, SLN biopsy
(SLNB) with Tc-99m radiocolloid based lymphoscinti-
graphy has gained popularity as an optimal technique
which provides accurate staging of axillary lymph nodes
with decreased morbidity. In addition, the minimally inva-
sive approach has increased quality of life and cost effec-
tiveness for the management of patients with clinically
negative axillary lymph nodes.(4) However, lymphoscin-
tigraphy using radioactive colloid raised safety issues on
radiation exposure to surgical staff, contamination of
surgical equipment, and the disposal of radioactive waste.
Radiation exposure to surgical staff during SLNB using
radiolabeled colloid is the topic of the study by Bekis et
al.(5) in this issue of the Journal of Breast Cancer. The
study assessed the level of the radiation dose to surgical
staff during surgical probe applications in 3 patients with
breast cancer. Based on the measurement of radiation
dose by a Geiger Mueller counter, the whole body dose
to the senior surgeon was calculated well below the annual
radiation dose limit (1,000 μSV/year) for a member of the
public by the International Commission on Radiological
Protection. They confirmed that the radiation risk to the
surgical staff from SLNB with radiolabeled colloid is low
and the procedure can be safely performed by the sur-
geons. The measurement of exposure rates for radiation
by a Geiger Mueller counter seems to be easy and inex-
pensive. However, it could be more difficult to translate
the information to conditions in the daily practice of the
surgeon.(6) Instead, the actual measurement of radiation
dose using thermoluminescent dosimeter (TLD) seems
to be more suitable. Until now, studies on measurement
of the radioactivity, radiation exposure, or radiation dose
for lymphoscintigraphy and SLN dissection have been
reported to resolve radiation safety issues.(7-10) All
reports in the literature showed that radiation exposure
from lymphoscintigraphy and SLNB to surgical staff
and pathologists is very low. The surgeon’s hands and
abdominal wall was exposed to the most radiation. The
average radiation exposure to the surgeon’s abdomen
ranged from 0.34 to 10 μSV (average 5.8 μSV) and the
average radiation exposure to the hands ranged from
40 to 98 μSV (average 63.4 μSV). Even after accounting
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for the differences in surgical method and time, radio-
tracer injected, time interval between injection and surgery,
the radiation exposure in all of these studies showed
that the radiation exposure to the surgeon was minimal.
Considering that the whole body effective dose limit per
year for public members is 1 mSV (20 mSV for radiation
workers), surgeons can safely perform 200 to 500 oper-
ations per year to reach the annual dose limit for public
members. Therefore, personal dosimetry is not required
for surgical staff although radiation safety training seems
helpful for all personnel involved in the procedure. Because
the highest radiation exposure recorded was during the
time of injection of the radiopharmaceutical (maximal
dose recorded: hand exposure 160 μV),(10) it is recom-
mended to prepare and inject radiotracer by experienced
nuclear medicine professionals. Since most of the radio-
tracer is localized in the injection site (>95%) and that the
radioactivity is detected in the lymph nodes after surgery
(91%),(7,8) it is required to keep surgical specimens in
special area for appropriate time to minimize the radiation
exposure to the pathologists. Keeping all the recommen-
dations described above would maximize radiation safety
from lymphoscintigraphy and SLNB to stay safely within
the concept of As Low As Reasonably Achievable (ALARA).
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